243 related articles for article (PubMed ID: 22689290)
1. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
[TBL] [Abstract][Full Text] [Related]
2. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
[TBL] [Abstract][Full Text] [Related]
3. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
4. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
[TBL] [Abstract][Full Text] [Related]
5. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
[TBL] [Abstract][Full Text] [Related]
6. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
[TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
8. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
Yıldız T; Oğuzhanoğlu NK; Topak OZ
Turk J Med Sci; 2023 Feb; 53(1):253-263. PubMed ID: 36945926
[TBL] [Abstract][Full Text] [Related]
9. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
[TBL] [Abstract][Full Text] [Related]
10. A 6-month follow-up study on response and relapse rates following an acute trial of repetitive transcranial magnetic stimulation in patients with major depression.
Arici C; Benatti B; Cafaro R; Cremaschi L; Degoni L; Pozzoli S; Oldani L; Molteni L; Giorgetti F; Priori A; Viganò C; Dell'Osso B
CNS Spectr; 2022 Feb; 27(1):93-98. PubMed ID: 32883389
[TBL] [Abstract][Full Text] [Related]
11. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
14. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD).
Benadhira R; Thomas F; Bouaziz N; Braha S; Andrianisaina PS; Isaac C; Moulier V; Januel D
Psychiatry Res; 2017 Dec; 258():226-233. PubMed ID: 28844559
[TBL] [Abstract][Full Text] [Related]
15. Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial.
Krstić J; Buzadžić I; Milanović SD; Ilić NV; Pajić S; Ilić TV
J ECT; 2014 Dec; 30(4):325-31. PubMed ID: 24625704
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
[TBL] [Abstract][Full Text] [Related]
17. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
[TBL] [Abstract][Full Text] [Related]
18. Early relapse (ER) transcranial magnetic stimulation (TMS) in treatment resistant major depression.
Pridmore S; Erger S; Rybak M; Kelly E; May T
Brain Stimul; 2018; 11(5):1098-1102. PubMed ID: 29805096
[TBL] [Abstract][Full Text] [Related]
19. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
